These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2428873)

  • 1. Morphology and lytic mechanisms of interleukin 3-dependent natural cytotoxic cells: tumor necrosis factor as a possible mediator.
    Jadus MR; Schmunk G; Djeu JY; Parkman R
    J Immunol; 1986 Nov; 137(9):2774-83. PubMed ID: 2428873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural cytotoxic activity in a cloned natural killer cell line is mediated by tumor necrosis factor.
    Richards AL; Dennert G; Pluznik DH; Takagaki Y; Djeu JY
    Nat Immun Cell Growth Regul; 1989; 8(2):76-88. PubMed ID: 2761550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cytotoxic cell-specific cytotoxic factor produced by IL-3-dependent basophilic/mast cells. Relationship to TNF.
    Richards AL; Okuno T; Takagaki Y; Djeu JY
    J Immunol; 1988 Nov; 141(9):3061-6. PubMed ID: 3262677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural cytotoxic cells and tumor necrosis factor activate similar lytic mechanisms.
    Patek PQ; Lin Y; Collins JL
    J Immunol; 1987 Mar; 138(5):1641-6. PubMed ID: 3805728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-alpha is not the sole mediator of WEHI-164 tumour cell killing in natural cytotoxicity.
    Clarke GR; Shirzadeh H; Pang G; Beagley KW; Burton RC; Smart YC
    Cytokine; 1997 Apr; 9(4):254-62. PubMed ID: 9112334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediation of mouse natural cytotoxic activity by tumour necrosis factor.
    Ortaldo JR; Mason LH; Mathieson BJ; Liang SM; Flick DA; Herberman RB
    Nature; 1986 Jun 12-18; 321(6071):700-2. PubMed ID: 3520339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural cytotoxic (NC) cell activity in basophilic cells: release of NC-specific cytotoxic factor by IgE receptor triggering.
    Okuno T; Takagaki Y; Pluznik DH; Djeu JY
    J Immunol; 1986 Jun; 136(12):4652-8. PubMed ID: 2940298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An IL-3-induced splenic NC-1.1+ mast cell line mediates natural cytotoxicity independent of TNF-alpha.
    Shirzadeh H; Clarke GR; McNeil HP; Wang H; Burton RC; Smart YC
    Cell Immunol; 1996 Dec; 174(2):147-54. PubMed ID: 8954614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
    Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
    Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of stem cell factor on the ultrastructure of Fc epsilon RI+ cells developing in IL-3-dependent murine bone marrow-derived cell cultures.
    Rottem M; Goff JP; Albert JP; Metcalfe DD
    J Immunol; 1993 Nov; 151(9):4950-63. PubMed ID: 7691960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro generated mast cells express natural cytotoxicity against tumour cells.
    Ghiara P; Boraschi D; Villa L; Scapigliati G; Taddei C; Tagliabue A
    Immunology; 1985 Jun; 55(2):317-24. PubMed ID: 3924820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages.
    Decker T; Lohmann-Matthes ML; Gifford GE
    J Immunol; 1987 Feb; 138(3):957-62. PubMed ID: 3492537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan.
    Razin E; Ihle JN; Seldin D; Mencia-Huerta JM; Katz HR; LeBlanc PA; Hein A; Caulfield JP; Austen KF; Stevens RL
    J Immunol; 1984 Mar; 132(3):1479-86. PubMed ID: 6198393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and phenotypic characterization of human basophilic cells derived from dispersed fetal liver with murine T cell factors.
    Seldin DC; Caulfield JP; Hein A; Osathanondh R; Nabel G; Schlossman SF; Stevens RL; Austen KF
    J Immunol; 1986 Mar; 136(6):2222-30. PubMed ID: 2419426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
    Owen-Schaub LB; Gutterman JU; Grimm EA
    Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective growth of murine newborn-derived suppressor cells and their probable mode of action.
    Jadus MR; Parkman R
    J Immunol; 1986 Feb; 136(3):783-92. PubMed ID: 2934478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humans express natural cytotoxic (NC) cell activity that is similar to murine NC cell activity.
    Collins JL; Kao MS; Patek PQ
    J Immunol; 1987 Jun; 138(12):4180-4. PubMed ID: 3584975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.